ROE 23%, ROA 8% growing at 25% with Affordable Care Act tailwind. Only 13.6 x earnings for 25% growth. The growth is in new reimbursements from ACA. 40% of trips are either not paid or paid at Medicaid rates. ACA will pay at Medicare scheduled rates. This is all found money for AIRM which fall to the bottom line. AIRM always has highly volitile 1Q's due to weather. This provides a buying opportunity. The 20% short interest will provide a short covering opportunity. AIRM will sell out to private equity at some point as cash flows are very high and stable. PHII is another company with a medical evac sub that will be acquired.